drugset / Trial / NCT07269769
A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the TSL-TCM-SHJSMW-Ⅲ study is to study the efficacy and safety of Sanhuang Jingshiming Pills in subjects with Neovascular Age-Related Macular Degeneration.
Timeline
- Start
- 2026-04-30
- Primary completion
- 2031-12-31
- Completion
- 2031-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sanhuang Jingshiming | Unknown | 1 unknown | — |
| Background | Ranibizumab | Monoclonal antibody | — | — |
Indications
No indication recorded.